DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Endocyte, Inc. (NASDAQ: ECYT)

6.24 -0.10 (-1.50%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ECYT $6.24 -1.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.32
Previous Close $6.34
Daily Range $6.18 - $6.55
52-Week Range $5.31 - $33.70
Market Cap $260.3M
P/E Ratio 25.34
Dividend (Yield) $0.00 (0.0%)
Volume 941,390
Average Daily Volume 820,403
Current FY EPS $0.03

Sector

Healthcare

Industry

Drugs

Endocyte, Inc. (ECYT) Description

Endocyte Inc is a biopharmaceutical Company developing targeted therapies for the treatment of cancer and inflammatory diseases. It uses its proprietary technology to create novel small molecule drug conjugates or SMDCs and companion imaging diagnose. Website: http://www.endocyte.com/

News & Commentary Rss Feed

Why Endocyte, Inc. Stock Briefly Spiked Higher

Endocyte stock was briefly among today's top gainers after the company released an encouraging interim update on experimental drug vintafolide as a possible non-small cell lung cancer treatment.

Others Overlooked Endocyte (ECYT), Should You Buy It Now? - Tale of the Tape

Why Endocyte (ECYT) Could Be Positioned for a Surge? - Tale of the Tape

Why Endocyte (ECYT) Could Be Positioned for a Surge? - Tale of the Tape

Can Endocyte (ECYT) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape

Can Endocyte (ECYT) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape

Endocyte, Inc. (ECYT) in Focus: Stock Surges 18% - Tale of the Tape

Endocyte's (ECYT) CEO Ron Ellis on Q3 2014 Results - Earnings Call Transcript

Will Endocyte (ECYT) Miss This Earnings Season? - Analyst Blog

Why Endocyte (ECYT) Stock Is Declining Today

Benzinga's Top Downgrades

Endocyte's TARGET Interim Data Positive for Lung Cancer - Analyst Blog

See More ECYT News...

ECYT's Top Competitors

ECYT $6.24 (-1.50%)
Current stock: ECYT
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY